Assessment of treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000028032
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Rupture of hepatocellular carcinoma 2)History of surgical or endoscopic treatment of bile duct 3)Prominent arterioportal or arteriovenous shunts 4)Dissection or stenosis of 50% or more in the celiac trunk or hepatic artery 5)Hepatic coma or severe psychiatric disorder 6)Severe drug allergy including SPIO or iodine contast allergy 7)Inadequate patients to undergo the procedure safely
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method local recurrence
- Secondary Outcome Measures
Name Time Method